Trial
NCT00347438
Capecitabine as NeoAdjuvant Therapy in Locally Advanced Breast Cancer
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Chicago
Collaborators
Breast Cancer Research Foundation; Roche Pharma AG
Condition
Breast Cancer
Intervention
Capecitabine
Why stopped
a result of slow accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-12-14